Status:
COMPLETED
Prevalence and Risk Factors of Epiretinal Membrane in Diabetic and Non-diabetic Patients
Lead Sponsor:
Laurence Postelmans
Conditions:
Epiretinal Membrane
Eligibility:
All Genders
15+ years
Brief Summary
Numerous terms have been used to describe epiretinal membrane (ERM): macular pucker, epimacular membrane, surface-wrinkling retinopathy, cellophane maculopathy and preretinal macular fibrosis. It is, ...
Eligibility Criteria
Inclusion
- Subjects examined in the general or diabetes screening consultations of the Ophthalmology Department of the CHU Brugmann Hospital
Exclusion
- Women pregnant or breast-feeding
- Hypersensitivity to tropicamide
- Any macular pathology other than diabetic maculopathy
- Prior retinal photocoagulation
- Prior intravitreal injection
- Prior retinal surgery
Key Trial Info
Start Date :
December 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 10 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03362580
Start Date
December 12 2017
End Date
October 10 2019
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020